Boost Biosystems Creates New Initiatives

ScanBaltBiosystems technology, the by-product of biology and microsystems components interfacing, addresses modern biotechnology and medicine concerns in developed countries. For its part, the EU-funded project Boost Biosystems seeks to fuel cooperation between academia and industry in the cross-disciplinary field of biosystems technologies in the ScanBalt BioRegion, the life science metacluster in the Baltic Sea region. Funding for the project stands at EUR 444,208.

To date, the project partners have succeeded in setting up around 12 proposals or collaborations. Project coordinator Dr Frank Graage, from Steinbeis team Northeast, said: "The project informed over 200 actors about biosystem potential in various regional events and assisted 45 small and medium-sized enterprises (SMEs) in setting up EU FP7 proposals or collaborations in the biosystems field."

Boost Biosystems, according to the partners, is helping establish critical mass, creating a platform for knowledge transfer in the field, integrating emerging economies of new EU Member States, and bolstering SMEs. By making headway and intensifying research and technology development (RTD) cooperation between academia and SMEs, Boost Biosystems is raising the awareness of biosystems technology and increasing the competitiveness of SMEs. The project partners say that while the SMEs have the potential to promote innovation, they also need the support from academia and industry to bring their work to fruition.

A key focus area with a lot of potential for the region is 'new diagnostics', said the project partners. An example of this is the Baltic Center of Innovative Diagnostics by ScanBalt Knowledge Network Molecular Diagnostics. The partners say this centre will be the place where future cooperation deals will be clinched. Not only has Boost Biosystems already connected stakeholders and project participants with potential partners in the region, but it has provided know-how in the management of EU projects.

Another key example is the latest Finnish cluster strategy intensifying cooperation between HealthBIO, Nano- and ICT clusters, effectively making the strategy comply with the interdisciplinary approach of biosystems and new diagnostics.

Insufficient cooperation between actors and the general lack of knowledge of users, like clinicians, suppliers and markets, has proved troublesome for getting innovative biosystems technologies to the sectors. And so the lacklustre implementation of biosystems technologies leaves a void across the different fields.

Boost Biosystems is targeting biosystems technology in the life sciences and biotechnology, and eyeing technical and disease-related aspects. These include diagnostics, pharmacogenomics and in vitro tests.

Boost Biosystems' results and success stories were presented at the Seventh ScanBalt Forum and Biomaterials in Vilnius, Lithuania in September. Forum participants got a taste of how ScanBalt members seek to establish an SME support service that would back SMEs in transnational collaborations and EU research proposals.

Boost Biosystems is comprised of six partners, specifically Steinbeis Northeast (project coordinator, Germany), ScanBalt, Norgenta GmbH (Germany), Tartu Biotechnology Park (Estonia), Culminatum Ltd (Finland) and Center of Technology Transfer (Poland).

For further information, please visit:
http://www.scanbalt.org

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...